Previous close | 0.0140 |
Open | 0.0130 |
Bid | 0.0130 x 0 |
Ask | 0.0140 x 0 |
Day's range | 0.0130 - 0.0130 |
52-week range | 0.0040 - 0.0140 |
Volume | |
Avg. volume | 7,353,511 |
Market cap | 49.192M |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings date | 29 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
OncoSil Medical ( ASX:OSL ) Full Year 2024 Results Key Financial Results Net loss: AU$12.4m (loss widened by 9.1% from...
The recent price decline of 20% in OncoSil Medical Limited's ( ASX:OSL ) stock may have disappointed insiders who...
Key Insights OncoSil Medical's Annual General Meeting to take place on 28th of November CEO Nigel Lange's total...